Symbol
CTMX on Nasdaq
Investment type
Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership
48.9K shares
Security Ownership
0.02%

Seven Fleet Master Fund LP ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

2025-11-14 - Seven Fleet Master Fund LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 48.9K shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 0.02% percent ownership of the company.